Cancer Clinical Trial
— FertioncoOfficial title:
Decisional Conflict of Young Cancer Patients With Regard to Fertility Preservation - Effects of an Online Decision-aid Tool
| NCT number | NCT02404883 |
| Other study ID # | 2014-265 |
| Secondary ID | |
| Status | Completed |
| Phase | N/A |
| First received | |
| Last updated | |
| Start date | October 2014 |
| Est. completion date | December 2018 |
| Verified date | January 2019 |
| Source | University Hospital, Basel, Switzerland |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
Women who are diagnosed with cancer during their reproductive lifespan might be confronted
with impaired fertility. Nowadays a number of fertility preservation options are available.
Decisions about whether and how to protect fertility have to be made in a very short time
period, right after cancer diagnosis and before start of treatment. The psychological impact
for patients is considerable. This project aims at developing a standardized decision-aid
tool to support the decision-making process about fertility preservation in young cancer
patients. It is designed as an online decision-aid tool. A web-based tool is perfectly
designed for this target group and offers new possibilities providing flexible and
individually tailored information.
The aim of the study is to examine the benefits of the online decision-aid tool compared with
standard counseling (usual care). Decisional conflict is measured immediately after
counseling as well as one month later. One year after counseling, decisional regret is being
evaluated additionally. If the decision-aid tool proves to be helpful and useful, the online
design allows making it available for a wide range of concerned patients.
| Status | Completed |
| Enrollment | 79 |
| Est. completion date | December 2018 |
| Est. primary completion date | December 2018 |
| Accepts healthy volunteers | No |
| Gender | Female |
| Age group | 16 Years to 40 Years |
| Eligibility |
Inclusion Criteria: - Female patients - Age 16 to 40 years - German speaking - Access to a computer - Pre-menopausal at time of diagnosis - Not yet having started (adjuvant) cancer therapy - family planning not completed Exclusion Criteria: - Cancer treatment not affecting reproductive function |
| Country | Name | City | State |
|---|---|---|---|
| Switzerland | Universitätsspital Frauenklinik | Basel | Basel-Stadt |
| Lead Sponsor | Collaborator |
|---|---|
| University Hospital, Basel, Switzerland | Swiss Bridge |
Switzerland,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | change (reduction) of decisional conflict (Decisional Conflict Scale) | with the | 3 times: within 5 days after fertility preservation counseling, one month after counseling, 12 month after counseling | |
| Secondary | change (reduction) of decisional regret (Decisional Regret Scale) | with the Decisional Regret Scale | twice: 1 month after fertility preservation counseling, 12 month after counseling | |
| Secondary | change (increase) of knowledge about fertility preservation (questionnaire) | with a questionnaire which assess the knowledge about various fertility preservation methods | twice: within 5 days after fertility preservation counseling, 1 month after counseling | |
| Secondary | helpfulness and satisfaction of decision-aid tool (questionnaire) | questionnaire to assess helpfulness and satisfaction of tool only for the intervention group, who used the decision-aid tool | twice: within 5 days after fertility preservation counseling, 1 month after counseling |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
| Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
| Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
| Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
| Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
| Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
| Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
| Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
| Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
| Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
| Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
| Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
| Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
| Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
| Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
| Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
| Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
| Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|